C6-ceramide maintains elevated cytosolic calcium levels in activated platelets.
The effects of cell-permeable C2 and C6-ceramides on human platelet responses were investigated. In thrombin-activated platelets, C6(5-30 microM) potentiated Ca2+ mobilization and Ca2+ influx, and decreased the rate of removal of Ca2+ from cytosol. The effect of C2 was not significant. Phorbol ester or calyculin A inhibition of thrombin-induced rises in platelet [Ca2+]i was attenuated by C6. Assays show that C6 either prolonged the generation, or retarded the metabolism of inositol trisphosphates. Previous studies indicate that protein kinase C (PKC) acts in a negative feedback manner by inhibiting phosphatidylinositol breakdown, accelerating inositol trisphosphate metabolism, and increasing Ca2+ pump activity. C6 may counter these PKC effects indirectly. The synthetic ceramides inhibited platelet aggregation weakly and had no effect on pleckstrin (p47) phosphorylation. Recently we reported that C2 but not C6 inhibits superoxide generation and store-regulated Ca2+ influx in neutrophils at similar concentrations. Cellular differences in ceramide metabolism or ceramide-sensitive enzymes and their substrates may account for the disparate results.